Loading...
HAPV3 logo

Hapvida Participações e Investimentos S.A.BOVESPA:HAPV3 Aktienübersicht

Marktkapitalisierung R$17.8b
Aktienkurs
R$35.86
Mein Marktwert
R$59.04
39.3% unterbewertet intrinsischer Abschlag
1Y-40.5%
7D-2.0%
Wert des Portfolios
​
Siehe

Hapvida Participações e Investimentos S.A.

BOVESPA:HAPV3 Lagerbericht

Marktkapitalisierung: R$17.8b

Hapvida Participações e Investimentos (HAPV3) Aktienübersicht

Hapvida Participações e Investimentos S.A. ist zusammen mit ihren Tochtergesellschaften im Gesundheitssektor in Brasilien tätig. Mehr Details

HAPV3 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung4/6
Künftiges Wachstum4/6
Vergangene Leistung0/6
Finanzielle Gesundheit3/6
Dividenden0/6

Belohnungen

28.7% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 59.4% pro Jahr

Risikoanalyse

Bei unseren Risikoprüfungen wurden keine Risiken für HAPV3 festgestellt.

HAPV3 Community Fair Values

Create Narrative

See what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.

HAPV3 logo
Hapvida Participações e Investimentos

Rising Claims And Costly Integrations Will Hinder Brazil's Healthcare Delivery

Key Takeaways Persistent medical inflation, high claims ratios, and integration challenges risk eroding profitability and margins despite efforts in verticalization and network expansion. Economic volatility, growing competition, and increased regulatory pressures threaten revenue growth and customer retention amid shifting consumer sentiment and affordability concerns.
View narrative
R$31.85
FV
12.6% überbewertet intrinsischer Abschlag
8.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
24 days ago author updated this narrative
HAPV3 logo
Hapvida Participações e Investimentos

Telemedicine And AI Will Revolutionize Brazil's Healthcare

Key Takeaways Aggressive integration, innovation in care delivery, and rapid hospital expansion are expected to boost growth, margins, and long-term pricing power beyond current expectations. AI-driven digital health, tailored products, and government partnerships position Hapvida to outpace competitors and consolidate market share as Brazil's healthcare landscape evolves.
View narrative
R$85.44
FV
58.0% unterbewertet intrinsischer Abschlag
12.95%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
24 days ago author updated this narrative
HAPV3 logo
Hapvida Participações e Investimentos

Urban Clinic Expansion And AI Integration Will Transform Brazilian Healthcare

Key Takeaways Expansion of healthcare infrastructure and digital innovations are driving operational efficiency, improved care, and increased market share among Brazil's growing insured population. Integration of acquisitions and process streamlining supports cost control, revenue predictability, and long-term margin growth through organic expansion and risk management.
View narrative
R$59.04
FV
39.3% unterbewertet intrinsischer Abschlag
8.59%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
19 days ago author updated this narrative
View Stock Community

Hapvida Participações e Investimentos S.A. Wettbewerber

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für Hapvida Participações e Investimentos
Historische Aktienkurse
Aktueller AktienkursR$35.86
52-Wochen-HochR$60.90
52-Wochen-TiefR$29.70
Beta0.32
1 Monat Veränderung-13.15%
3 Monate Veränderung0.70%
1 Jahr Veränderung-40.53%
3 Jahre Veränderung-69.03%
5 Jahre Veränderung-81.48%
Veränderung seit IPO-58.57%

Aktuelle Nachrichten und Updates

These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Reasonably Well

Sep 29
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Reasonably Well

Investors Appear Satisfied With Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Prospects As Shares Rocket 28%

Aug 31
Investors Appear Satisfied With Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Prospects As Shares Rocket 28%

Recent updates

These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Reasonably Well

Sep 29
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Reasonably Well

Investors Appear Satisfied With Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Prospects As Shares Rocket 28%

Aug 31
Investors Appear Satisfied With Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Prospects As Shares Rocket 28%

These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Extensively

Jul 01
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Extensively

Getting In Cheap On Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Is Unlikely

Apr 18
Getting In Cheap On Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Is Unlikely

These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Extensively

Mar 17
These 4 Measures Indicate That Hapvida Participações e Investimentos (BVMF:HAPV3) Is Using Debt Extensively
User avatar

Brazilian Healthcare Expansion And Tech Investments Will Drive Growth And Boost Margins

Expansion and upgrades of healthcare infrastructure in Brazil may drive growth in membership and revenue.

Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing

Dec 18
Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Dec 16
Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Hapvida Participações e Investimentos' (BVMF:HAPV3) Performance Is Even Better Than Its Earnings Suggest

Nov 19
Hapvida Participações e Investimentos' (BVMF:HAPV3) Performance Is Even Better Than Its Earnings Suggest

Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 15
Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet

Jul 16
Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet

Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing

Apr 28
Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing

Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?

Mar 28
Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?

Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)

Jan 07
Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)

Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt

Dec 11
Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Sep 11
Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Jun 08
Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?

Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt

Feb 27
Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt

Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet

Nov 11
Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet

At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?

Sep 11
At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?

Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden

Jul 08
Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden

Aktionärsrenditen

HAPV3BR HealthcareBR Markt
7D-2.0%0.6%-1.5%
1Y-40.5%7.9%0.2%

Rendite im Vergleich zur Industrie: HAPV3 unter dem Niveau der Branche BR Healthcare , die im vergangenen Jahr eine Rendite von 7.9% erzielte.

Rendite vs. Markt: HAPV3 hinter dem Markt BR zurück, der im vergangenen Jahr eine Rendite von 0.2 erzielte.

Preisvolatilität

Is HAPV3's price volatile compared to industry and market?
HAPV3 volatility
HAPV3 Average Weekly Movement4.9%
Healthcare Industry Average Movement6.1%
Market Average Movement4.2%
10% most volatile stocks in BR Market8.4%
10% least volatile stocks in BR Market2.0%

Stabiler Aktienkurs: HAPV3 hatte in den letzten 3 Monaten im Vergleich zum BR -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: HAPV3Die wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
1979n/aJorge Fontoura Pinheiro de Limari.hapvida.com.br

Hapvida Participações e Investimentos S.A. ist zusammen mit seinen Tochtergesellschaften im Gesundheitssektor in Brasilien tätig. Das Unternehmen bietet Krankenversicherungspläne über seine klinischen, ambulanten und Krankenhausnetzwerke sowie Zahnversicherungspläne über ein zugelassenes Netzwerk an. Darüber hinaus bietet es medizinische und paramedizinische Dienste, Labor-, Diagnose-, Bildgebungs- und Ultraschalldienste, Gesundheitsmanagementdienste sowie medizinische und Krankenhauspflegedienste an.

Hapvida Participações e Investimentos S.A.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Hapvida Participações e Investimentos im Vergleich zum Marktanteil des Unternehmens?
HAPV3 grundlegende Statistiken
MarktanteilR$17.75b
Gewinn(TTM)-R$478.60m
Umsatz(TTM)R$29.49b
0.6x
Kurs-Umsatz-Verhältnis
-37.1x
Kurs-Gewinn-Verhältnis

Ist HAPV3 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
HAPV3 Gewinn- und Verlustrechnung (TTM)
EinnahmenR$29.49b
Kosten der EinnahmenR$25.40b
BruttogewinnR$4.09b
Sonstige AusgabenR$4.57b
Umsatz-R$478.60m

Zuletzt gemeldete Gewinne

Jun 30, 2025

Datum des nächsten Gewinnberichts

Nov 12, 2025

Gewinn per Aktie (EPS)-0.97
Bruttomarge13.87%
Nettogewinnspanne-1.62%
Schulden/Eigenkapital-Verhältnis27.3%

Wie hat sich HAPV3 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2025/10/04 08:47
Aktienkurs zum Tagesende2025/10/03 00:00
Gewinne2025/06/30
Jährliche Einnahmen2024/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Hapvida Participações e Investimentos S.A. wird von 22 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
William BertanBB Banco de Investimento S.A.
Flavio YoshidaBofA Global Research
Frederico MendesBradesco S.A. Corretora de Títulos e Valores Mobiliários